Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
articles containing video clips
colloids
dosage forms
drug delivery devices
gels
histopathology
infectious causes of cancer
male genital neoplasia
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
rtt
companies based in minneapolis
companies established in 1895
companies listed on the new york stock exchange
investment banks
minnesota
u.s. bancorp
What
absorbable
16
×
augmenix
16
×
company
develops
hydrogels
manufactures
medical
organs
press
protect
radiotherapy
release
risk
sells
separate
technology
proprietary
announced
today
prostate
hydrogel
spaceoar
announces
cancer
annual
radiation
conference
data
healthcare
new
present
treated
american
clinical
international
j.p
medicare
morgan
patient
patients
Language
Current search:
augmenix
×
absorbable
×
@venturebeat.com
6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
Augmenix Partners with Us TOO International to Stream Live Webcast and Q & A on Prostate Cancer Radiation Therapy
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
7 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com
7 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
7 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
7 years ago
Augmenix Ranked as One of America’s Fastest-Growing Private Companies for Second Year
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30